Nalaganje...

Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity

Background: Type 2 diabetes mellitus (DM2), which mainly develops from visceral obesity, is a socially significant disease. Reduction of losses from DM2 is a priority in modern medicine development. Glucagon-like peptide-1 receptor agonists (aGLP-1) present one of few groups of antidiabetic drugs th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ekaterina V. Tikhonenko, Alina Y. Babenko, Evgeny V. Shlyakhto
Format: Artigo
Jezik:Inglês
Izdano: Endocrinology Research Centre 2018-12-01
Serija:Ожирение и метаболизм
Teme:
Online dostop:https://www.omet-endojournals.ru/jour/article/view/9584
Oznake: Označite
Brez oznak, prvi označite!